Tuberculosis of the central nervous system in immunocompromised patients: HIV infection and solid organ transplant recipients

Clinical Infectious Diseases

Volumn 53, Issue 9, 2011, Pages 915-926

  Nelson, Christina A ^a,b   Zunt, Joseph R ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZATHIOPRINE; CAPREOMYCIN; CORTICOSTEROID; CYCLOSERINE; CYCLOSPORIN; EFAVIRENZ; ETHAMBUTOL; ETHIONAMIDE; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; ISONIAZID; KANAMYCIN; LEVOFLOXACIN; MOXIFLOXACIN; NEVIRAPINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; OKT 3; PROTIONAMIDE; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RAPAMYCIN; RIFABUTIN; RIFAMPICIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; STREPTOMYCIN; T LYMPHOCYTE ANTIBODY; TACROLIMUS; UNINDEXED DRUG; ZIDOVUDINE;

ABSCESS; ANTIBIOTIC RESISTANCE; ANTIVIRAL THERAPY; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM TUBERCULOSIS; CEREBROSPINAL FLUID EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); GRAFT RECIPIENT; HEART ARRHYTHMIA; HEART TRANSPLANTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INFECTION SENSITIVITY; INTRACRANIAL TUBERCULOMA; KIDNEY TRANSPLANTATION; LIVER TOXICITY; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MILIARY TUBERCULOSIS; MORBIDITY; MORTALITY; MULTIDRUG RESISTANT TUBERCULOSIS; NEPHROTOXICITY; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME; TUBERCULOUS ABSCESS; TUBERCULOUS MENINGITIS;

CENTRAL NERVOUS SYSTEM DISEASES; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; ORGAN TRANSPLANTATION; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 80054064536     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir508     Document Type: Article

References (114)

1. Phypers M, Harris T, Power C. CNS tuberculosis: a longitudinal analysis of epidemiological and clinical features. Int J Tuberc Lung Dis 2006; 10:99-103. (Pubitemid 43266285)
2. Rock RB, Olin M, Baker CA, Molitor TW, Peterson PK. Central nervous system tuberculosis: pathogenesis and clinical aspects. Clin Microbiol Rev 2008; 21:243-61. (Pubitemid 351555506)
3. Getahun H, Gunneberg C, Granich R, Nunn P. HIV infectionassociated tuberculosis: the epidemiology and the response. Clin Infect Dis 2010; 50(Suppl 3):S201-7.
4. Rana FS, Hawken MP, Mwachari C, et al. Autopsy study of HIV-1-positive and HIV-1-negative adult medical patients in Nairobi, Kenya. J Acquir Immune Defic Syndr 2000; 24:23-9. (Pubitemid 30447802)
5. Berenguer J, Moreno S, Laguna F, et al. Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med 1992; 326:668-72.
6. Azuaje C, Fernandez Hidalgo N, Almirante B, et al. Tuberculous meningitis: a comparative study in relation to concurrent human immunodeficiency virus infection. Enferm Infecc Microbiol Clin 2006; 24:245-50. (Pubitemid 43874421)
7. Torre-Cisneros J, Doblas A, Aguado JM, et al. Tuberculosis after solidorgan transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort. Clin Infect Dis 2009; 48:1657-65.
8. Aguado JM, Torre-Cisneros J, Fortun J, et al. Tuberculosis in solidorgan transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. Clin Infect Dis 2009; 48:1276-84.
9. Lawn SD, Bekker LG, Miller RF. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis 2005; 5:361-73. (Pubitemid 40779257)
10. Kingkaew N, Sangtong B, Amnuaiphon W, et al. HIV-associated extrapulmonary tuberculosis in Thailand: epidemiology and risk factors for death. Int J Infect Dis 2009; 13:722-9.
11. Singh N, Paterson DL. Mycobacterium tuberculosis infection in solidorgan transplant recipients: impact and implications for management. Clin Infect Dis 1998; 27:1266-77. (Pubitemid 29242482)
12. Lopez de Castilla D, Schluger NW. Tuberculosis following solid organ transplantation. Transpl Infect Dis 2010; 12:106-12.
13. Muñoz P, Rodr?́guez C, Bouza E. Mycobacterium tuberculosis infection in recipients of solid organ transplants. Clin Infect Dis 2005; 40:581-7. (Pubitemid 40270229)
14. Daikos GL, Cleary T, Rodriguez A, Fischl MA. Multidrug-resistant tuberculous meningitis in patients with AIDS. Int J Tuberc Lung Dis 2003; 7:394-8. (Pubitemid 36433135)
15. Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol 1974; 99:131-8.
16. Garg RK. Tuberculous meningitis. Acta Neurol Scand 2010; 122:75-90.
17. Verdon R, Chevret S, Laissy J-P, Wolff M. Tuberculous meningitis in adults: review of 48 cases. Clin Infect Dis 1996; 22:982-8. (Pubitemid 26260599)
18. Sutlas PN, Unal A, Forta H, Senol S, Kirbas D. Tuberculous meningitis in adults: review of 61 cases. Infection 2003; 31:387-91. (Pubitemid 38005368)
19. LincolnEM, SordilloVR, Davies PA.Tuberculousmeningitis in children. A review of 167 untreated and 74 treated patients with special reference to early diagnosis. J Pediatr 1960; 57:807-23.
20. Christensen AS, Andersen AB, Thomsen VO, Andersen PH, Johansen IS. Tuberculous meningitis in Denmark: a review of 50 cases. BMC Infect Dis 2011; 11:47.
21. Leonard JM, Des Prez RM. Tuberculous meningitis. Infect Dis Clin North Am 1990; 4:769-87.
22. Sanchez-Portocarrero J, Perez-Cecilia E, Jimenez-Escrig A, et al. Tuberculous meningitis: clinical characteristics and comparison with cryptococcal meningitis in patients with human immunodeficiency virus infection. Arch Neurol 1996; 53:671-6. (Pubitemid 26242218)
23. Croda MG, Vidal JE, Hernández AV, Dal Molin T, Gualberto FA, de Oliveira AC. Tuberculous meningitis in HIV-infected patients in Brazil: clinical and laboratory characteristics and factors associated with mortality. Int J Infect Dis 2010; 14:e586-91.
24. De Cock KM, Soro B, Coulibaly IM, Lucas SB. Tuberculosis and HIV infection in sub-Saharan Africa. JAMA 1992; 268:1581-7.
25. Dube MP, Holtom PD, Larsen RA. Tuberculous meningitis in patients with and without human immunodeficiency virus infection. Am J Med 1992; 93:520-4.
26. Thwaites GE, Duc Bang N, Huy Dung N, et al. The influence of HIV infection on clinical presentation, response to treatment, and outcome in adults with tuberculous meningitis. J Infect Dis 2005; 192:2134-41. (Pubitemid 41779213)
27. Katrak SM, Shembalkar PK, Bijwe SR, Bhandarkar LD. The clinical, radiological and pathological profile of tuberculous meningitis in patients with and without human immunodeficiency virus infection. J Neurol Sci 2000; 181:118-26.
28. Yechoor VK, Shandera WX, Rodriguez P, Cate TR. Tuberculous meningitis among adults with and without HIV infection: experience in an urban public hospital. Arch Intern Med 1996; 156:1710-6. (Pubitemid 26287128)
29. Porkert MT, Sotir M, Parrott-Moore P, Blumberg HM. Tuberculous meningitis at a large inner-city medical center. Am J Med Sci 1997; 313:325-31. (Pubitemid 27249086)
30. El Sahly HM, Teeter LD, Pan X, Musser JM, Graviss EA. Mortality associated with central nervous system tuberculosis. J Infect 2007; 55: 502-9. (Pubitemid 350082470)
31. Garcia-Monco JC. Central nervous system tuberculosis. Neurol Clin 1999; 17:737-59. (Pubitemid 29517307)
32. Arseni C. Two hundred and one cases of intracranial tuberculoma treated surgically. J Neurol Neurosurg Psychiat 1958; 21:308-11.
33. Bernaerts A, Vanhoenacker FM, Parizel PM, et al. Tuberculosis of the central nervous system: overview of neuroradiological findings. Eur Radiol 2003; 13:1876-90. (Pubitemid 36949714)
34. Dastur DK, Lalitha VS, Prabhakar V. Pathological analysis of intracranial space-occupying lesions in 1000 cases including children. 1. Age, sex and pattern; and the tuberculomas. J Neurol Sci 1968; 6:575-92.
35. Martinez-Vazquez C, Bordon J, Rodriguez-Gonzalez A, et al. Cerebral tuberculoma: a comparative study in patients with and without HIV infection. Infection 1995; 23:149-53.
36. Henderson C, Meyers B, Humayun Gultekin S, Liu B, Zhang DY. Intracranial tuberculoma in a liver transplant patient: first reported case and review of the literature. Am J Transplant 2003; 3:88-93. (Pubitemid 36306831)
37. Vishnubhotla S, Siddhartha B, Sivramakrishna G, Lakshmi AY, Kumaraswamy RM. Proptosis in a post-renal transplant patient with disseminated tuberculosis. Transpl Infect Dis 2009; 11:241-2.
38. Whiteman M, Espinoza L, Post MJ, Bell MD, Falcone S. Central nervous system tuberculosis in HIV-infected patients: clinical and radiographic findings. AJNR Am J Neuroradiol 1995; 16:1319-27.
39. Farrar DJ, Flanigan TP, Gordon NM, Gold RL, Rich JD. Tuberculous brain abscess in a patient with HIV infection: case report and review. Am J Med 1997; 102:297-301. (Pubitemid 27215607)
40. Vidal JE, Penalva de Oliveira AC, Bonasser Filho F, et al. Tuberculous brain abscess in AIDS patients: report of three cases and literature review. Int J Infect Dis 2005; 9:201-7. (Pubitemid 40827161)
41. Girgis N, Sultan Y, Farid Z, et al. Tuberculosis meningitis, Abbassia Fever Hospital-Naval Medical Research Unit No. 3-Cairo, Egypt, from 1976 to 1996. Am J Trop Med Hyg 1998; 58:28-34. (Pubitemid 28071406)
42. Kent SJ, Crowe SM, Yung A, Lucas CR, Mijch AM. Tuberculous meningitis: a 30-year review. Clin Infect Dis 1993; 17:987-94. (Pubitemid 23358742)
43. Hinman AR. Tuberculous meningitis at Cleveland Metropolitan General Hospital 1959 to 1963. Am Rev Respir Dis 1966; 85:670-3.
44. Mason RJ, ed. Murray and Nadel's textbook of respiratory medicine. 5th ed. Philadelphia, PA: Elsevier, 2010.
45. Leidl L, Mayanja-Kizza H, Sotgiu G, et al. Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD41 T-cells in HIV infection. Eur Respir J 2010; 35:619-26.
46. Thwaites GE, Chau TT, Stepniewska K, et al. Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet 2002; 360:1287-92. (Pubitemid 35284620)
47. Torok ME, Nghia HD, Chau TT, et al. Validation of a diagnostic algorithm for adult tuberculous meningitis. Am J Trop Med Hyg 2007; 77:555-9. (Pubitemid 351844336)
48. Kennedy DH, Fallon RJ. Tuberculous meningitis. JAMA 1979; 241: 264-8. (Pubitemid 9228429)
49. BayIndIr C, MeteÖ , Bilgic B. Retrospective study of 23 pathologically proven cases of central nervous system tuberculomas. Clin Neurol Neurosurg 2006; 108:353-7.
50. Kumar R, Pandey , Bose N, Sahay S. Tuberculous brain abscess: clinical presentation, pathophysiology and treatment (in children). Childs Nerv Syst 2002; 18:118-23. (Pubitemid 36024317)
51. Mayers MM, Kaufman DM, Miller MH. Recent cases of intracranial tuberculomas. Neurology 1978; 28:256-60. (Pubitemid 8312873)
52. Wasay M, Moolani MK, Zaheer J, Kheleani BA, Smego RA, Sarwari RA. Prognostic indicators in patients with intracranial tuberculoma: a review of 102 cases. J Pak Med Assoc 2004; 54:83-7. (Pubitemid 38525206)
53. Laguna F, Adrados M, Ortega A, Gonzalez-Lahoz JM. Tuberculous meningitis with acellular cerebrospinal fluid in AIDS patients. AIDS 1992; 6:1165-7.
54. Vidal JE, de Oliveira AC, Hernandez AV. CD41 T-cell count and cerebrospinal fluid findings in HIV-infected patients with tuberculous meningitis. Int J Tuberc Lung Dis 2010; 14:1496-7.
55. Cecchini D, Ambrosioni J, Brezzo C, et al. Tuberculous meningitis in HIV-infected and non-infected patients: comparison of cerebrospinal fluid findings. Int J Tuberc Lung Dis 2009; 13:269-71.
56. Puccioni-Sohler M, Brandao CO. Factors associated to the positive cerebrospinal fluid culture in the tuberculous meningitis. Arq Neuropsiquiatr 2007; 65:48-53. (Pubitemid 46569531)
57. Pepper DJ, Marais S, Maartens G, et al. Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series. Clin Infect Dis 2009; 48: e96-107.
58. Vidal JE, Hernandez AV, Oliveira AC, et al. Cerebral tuberculomas in AIDS patients: a forgotten diagnosis? Arq Neuropsiquiatr 2004; 62: 793-6. (Pubitemid 39361826)
59. Torok ME, Chau TT, Mai PP, et al. Clinical and microbiological features of HIV-associated tuberculous meningitis in Vietnamese adults. PLoS One 2008; 3:e1772.
60. Schutte CM. Clinical, cerebrospinal fluid and pathological findings and outcomes in HIV-positive and HIV-negative patients with tuberculous meningitis. Infection 2001; 29:213-7.
61. Monno L, Angarano G, Romanelli C, et al. Polymerase chain reaction for non-invasive diagnosis of brain mass lesions caused by Mycobacterium tuberculosis: report of five cases in human immunodeficiency viruspositive subjects. Tuber Lung Dis 1996; 77:280-4. (Pubitemid 26261318)
62. Singh KK, Nair MD, Radhakrishnan K, Tyagi JS. Utility of PCR assay in diagnosis of en-plaque tuberculoma of the brain. J Clin Microbiol 1999; 37:467-70. (Pubitemid 29056432)
63. Juan RS, Sanchez-Suarez C, Rebollo MJ, et al. Interferon gamma quantification in cerebrospinal fluid compared with PCR for the diagnosis of tuberculous meningitis. J Neurol 2006; 253:1323-30. (Pubitemid 44691557)
64. Tuon FF, Higashino HR, Lopes MI, et al. Adenosine deaminase and tuberculous meningitis: a systematic review with meta-analysis. Scand J Infect Dis 2010; 42:198-207.
65. de Almeida SM, Boritza K, Cogo LL, et al. Quantification of cerebrospinal fluid lactic acid in the differential diagnosis between HIV chronic meningitis and opportunistic meningitis. Clin Chem Lab Med 2011; 49:891-6.
66. Thwaites G, Chau TTH, Mai NTH, Drobniewski F, McAdam K, Farrar J. Tuberculous meningitis. J Neurol Neurosurg Psychiatr 2000; 68:289-99. (Pubitemid 30248701)
67. van der Weert EM, Hartgers NM, Schaaf HS, et al. Comparison of diagnostic criteria of tuberculous meningitis in human immunodeficiency virus-infected and uninfected children. Pediatr Infect Dis J 2006; 25:65-9. (Pubitemid 43361479)
68. Marais S, Pepper DJ, Marais BJ, Torok ME. HIV-associated tuberculous meningitis: diagnostic and therapeutic challenges. Tuberculosis (Edinb) 2010; 90:367-74.
69. Smith AB, Smirniotopoulos JG, Rushing EJ. From the archives of the AFIP: central nervous system infections associated with human immunodeficiency virus infection: radiologic-pathologic correlation. Radiographics 2008; 28:2033-58.
70. Cardenas G, Soto-Hernandez JL, Orozco RV, Silva EG, Revuelta R, Amador JL. Tuberculous brain abscesses in immunocompetent patients: management and outcome. Neurosurgery 2010; 67: 1081-7.
71. Vinnard C, Winston CA, Wileyto EP, MacGregor RR, Bisson GP. Isoniazid resistance and death in patients with tuberculous meningitis: retrospective cohort study. BMJ 2010; 341:c4451.
72. Thwaites GE, Lan NT, Dung NH, et al. Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis. J Infect Dis 2005; 192:79-88. (Pubitemid 40863860)
73. Berning SE, Cherry TA, Iseman MD. Novel treatment of meningitis caused by multidrug-resistant Mycobacterium tuberculosis with intrathecal levofloxacin and amikacin: case report. Clin Infect Dis 2001; 32:643-6. (Pubitemid 32565008)
74. Prasad K, Singh MB. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev 2008; (1);CD002244.
75. Hernandez-Albujar S, Arribas JR, Royo A, Gonzalez-Garcia JJ, Pena JM, Vazquez JJ. Tuberculous radiculomyelitis complicating tuberculous meningitis: case report and review. Clin Infect Dis 2000; 30: 915-21. (Pubitemid 32250329)
76. Naidoo DP, Desai D, Kranidiotis L. Tuberculous meningiomyeloradiculitis: a report of two cases. Tubercle 1991; 72:65-9.
77. Jain SK, Kwon P, Moss WJ. Management and outcomes of intracranial tuberculomas developing during antituberculous therapy: case report and review. Clin Pediatr (Phila) 2005; 44:443-50. (Pubitemid 40868908)
78. Centers for Disease Control and Prevention. Managing drug interactions in the treatment of HIV-related tuberculosis. Available at: http://www.cdc.gov/tb/ publications/guidelines/TB-HIV-Drugs/default. htm. Accessed 21 March 2011.
79. Schutz C, Meintjes G, Almajid F, Wilkinson RJ, Pozniak A. Clinical management of tuberculosis and HIV-1 co-infection. Eur Respir J 2010; 36:1460-81.
80. Sarma GR, Kailasam S, Nair NG, Narayana AS, Tripathy SP. Effect of prednisolone and rifampin on isoniazid metabolism in slow and rapid inactivators of isoniazid. Antimicrob Agents Chemother 1980; 18:661-6. (Pubitemid 11164134)
81. Blumberg HM, Burman WJ, Chaisson RE, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003; 167:603-62.
82. University of Liverpool. HIV drug interactions. Available at: http://www.hiv-druginteractions.org. Accessed 21 March 2011.
83. Davies P, Barnes P, Gordon S eds. Clinical tuberculosis, 4th ed. London, United Kingdom: Hodder Arnold, Hachette Livre, 2008.
84. Federico S, Carrano R, Capone D, Gentile A, Palmiero G, Basile V. Pharmacokinetic interaction between levofloxacin and ciclosporin or tacrolimus in kidney transplant recipients: ciclosporin, tacrolimus and levofloxacin in renal transplantation. Clin Pharmacokinet 2006; 45:169-75. (Pubitemid 43290829)
85. Burman WJ, Gallicano K, Peloquin C. Therapeutic implications of drug interactions in the treatment of human immunodeficiency virusrelated tuberculosis. Clin Infect Dis 1999; 28:419-29.
86. Ichai P, Saliba F, Antoun F, et al. Acute liver failure due to antitubercular therapy: strategy for antitubercular treatment before and after liver transplantation. Liver Transpl 2010; 16:1136-46.
87. Wells CD. Global impact of multidrug-resistant pulmonary tuberculosis among HIV-infected and other immunocompromised hosts: epidemiology, diagnosis, and strategies for management. Curr Infect Dis Rep 2010; 12:192-7.
88. Lou HX, Shullo MA, McKaveney TP. Limited tolerability of levofloxacin and pyrazinamide for multidrug-resistant tuberculosis prophylaxis in a solid organ transplant population. Pharmacotherapy 2002; 22:701-4. (Pubitemid 34596478)
89. Balis FM, Lester CM, Chrousos GP, et al. Differences in Cerebrospinal Fluid Penetration of Corticosteroids: Possible Relationship to the Prevention of Meningeal Leukemia. J Clin Oncol 1987; 5:202-207. (Pubitemid 17021600)
90. Thwaites G, Fisher M, Hemingway C, Scott G, Solomon T, Innes J. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect 2009; 59:167-87.
91. Centers for Disease Control and Prevention. Treatment of tuberculosis. MMWR Recomm Rep 2003; 52:1-77.
92. World Health Organization. Treatment of tuberculosis guidelines. 4th ed. Geneva, Switzerland: World Health Organization, 2010.
93. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis: emergency update 2008. Available at: http://whqlibdoc.who.int/publications/2008/9789241547581-eng.pdf. Accessed 18 June 2011.
94. Iseman MD. A clinician's guide to tuberculosis. Philadelphia: Lippincott Williams & Wilkins, 2000.
95. Thwaites GE, Nguyen DB, Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004; 351:1741-51.
96. Lawn SD, Torok ME, Wood R. Optimum time to start antiretroviral therapy during HIV-associated opportunistic infections. Curr Opin Infect Dis 2011; 24:34-42.
97. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services, 10 January 2011; 1-166. http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed 10 August 2011. Page 116.
98. WHO. Rapid advice: antiretroviral therapy for HIV infection in adults and adolescents-November 2009. Geneva, Switzerland:World Health Organization, 2009.
99. Torok ME, Yen NT, Chau TT, et al. Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)-associated tuberculous meningitis. Clin Infect Dis 2011; 52:1374-83.
100. Abdool Karim SS, Naidoo K, Grobler A, et al. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med 2010; 362:697-706.
101. Havlir D, Ive P, Kendall M, et al. International randomized trial of immediate vs early ART in HIV1 patients treated for TB: ACTG 5221 STRIDE Study. 18th Conference on Retroviruses and Opportunistic Infections. Boston, 2011.
102. Blanc FX, Sok T, Laureillard D. Significant enhancement in survival with early (2 weeks) vs. late (8 weeks) initiation of highly active antiretroviral treatment (HAART) in severely immunosuppressed HIV-infected adults with newly diagnosed tuberculosis. In: 18th International AIDS Conference (IAC). Vienna, Austria, 2010.
103. Patel VB, Padayatchi N, Bhigjee AI, et al. Multidrug-resistant tuberculous meningitis in KwaZulu-Natal, South Africa. Clin Infect Dis 2004; 38:851-6. (Pubitemid 38387234)
104. French MA, Lenzo N, John M, et al. Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med 2000; 1:107-15.
105. Worodria W, Massinga-Loembe M, Mazakpwe D, et al. Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapy. J Acquir Immune Defic Syndr 2011. epub ahead of print.
106. Crump JA, Tyrer MJ, Owen SJL, Han LY, Lipman MC, Johnson MA. Miliary tuberculosis with paradoxical expansion of intracranial tuberculomas complicating human immunodeficiency virus infection in a patient receiving highly active antiretroviral therapy. Clin Infect Dis 1998; 26:1008-9. (Pubitemid 28180357)
107. Marais S, Scholtz P, Pepper DJ, Meintjes G, Wilkinson RJ, Candy S. Neuroradiological features of the tuberculosis-associated immune reconstitution inflammatory syndrome. Int J Tuberc Lung Dis 2010; 14:188-96.
108. Meintjes G, Wilkinson RJ, Morroni C, et al. Randomized placebocontrolled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS 2010; 24: 2381-90.
109. Meyers BR, Papanicolaou GA, Sheiner P, Emre S,Miller C. Tuberculosis in orthotopic liver transplant patients: increased toxicity of recommended agents; cure of disseminated infection with nonconventional regimens. Transplantation 2000; 69:64-9. (Pubitemid 30062610)
110. Asano T, Kawamoto H, Asakuma J, Tanimoto T, Kobayashi H, Hayakawa M. Paradoxical worsening of tuberculosis after anti-TB therapy in a kidney transplant recipient. Transplant Proc 2000; 32: 1960-2.
111. Misra UK, Kalita J, Srivastava M, Mandal SK. Prognosis of tuberculous meningitis: a multivariate analysis. J Neurol Sci 1996; 137: 57-61. (Pubitemid 26132826)
112. Cecchini D, Ambrosioni J, Brezzo C, et al. Tuberculous meningitis in HIV-infected patients: drug susceptibility and clinical outcome. AIDS 2007; 21:373-4. (Pubitemid 46175052)
113. DeAngelis LM. Intracranial tuberculoma: case report and review of the literature. Neurology 1981; 31:1133-6.
114. Rungruanghiranya S, Ekpanyaskul C, Jirasiritum S, Nilthong C, Pipatpanawong K, Mavichak V. Tuberculosis in Thai renal transplant recipients: a 15-year experience. Transplant Proc 2008; 40:2376-9.